Evidence map›Paper›PMID 41945938›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2026

Enhancing Cervical Cancer Screening Among Northern Thai Women: Satisfaction with Self-Collected HPV DNA Testing under the National Program.

Wiyada Dankai, Phutanes Thangvorathum, Kwansuang Pukdee, Phanlapa Aithin, Rawadee Thongbai, Jidapa Noja, Naorn Sriwangdaeng, Suree Lekawanvijit

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wiyada DankaiDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0003-3914-1604
Phutanes ThangvorathumDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Kwansuang PukdeeDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Phanlapa AithinDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Rawadee ThongbaiDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Jidapa NojaDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Naorn SriwangdaengDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Suree LekawanvijitDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer is a leading cause of cancer-related morbidity and mortality among women in Thailand. Despite the availability of national cervical cancer screening programs, participation rates remain low in Northern Thailand due to barriers such as limited accessibility and discomfort with clinical sample collection. Self-collected HPV DNA testing offers a promising alternative to traditional screening methods by addressing these barriers and improving access to care.

objectiveCervical cancer is a major health burden in Thailand, yet participation in national screening programs remains low, particularly in Northern Thailand. This study evaluated satisfaction with self-collected HPV DNA testing and examined factors influencing screening acceptance to inform strategies for increasing uptake.

methodsA cross-sectional study was conducted among 299 women aged 30-60 years attending the national cervical cancer screening program at Maharaj Nakorn Chiang Mai Hospital. Participants performed self-collection following a demonstration and completed a five-point Likert scale satisfaction survey. Descriptive statistics and logistic regression were used to assess satisfaction and identify predictors of screening intention.

resultsMost participants (85.95%) strongly agreed that self-collected HPV DNA testing improved screening accessibility, and 100% found the process easy to follow. Mean satisfaction scores were high for accessibility (4.85/5), effectiveness (4.82/5), and reliability (4.81/5). No invalid samples were reported, and beta-globin Ct values confirmed high-quality sample collection (mean Ct = 29.00 ± 1.70). Education level significantly influenced screening intention (OR = 17.61, p = 0.039).

conclusionSelf-collected HPV DNA testing was highly satisfactory and could enhance national screening programs, especially in underserved populations.

Indexed as

DNA, ViralEarly Detection of CancerHuman Papillomavirus DNA TestsHuman Papillomavirus VirusesPapillomaviridaePapillomavirus InfectionsPatient SatisfactionSpecimen HandlingUterine Cervical NeoplasmsAdultCross-Sectional StudiesFemaleFollow-Up StudiesHumansMiddle AgedPrognosisDNA, Viralcervical cancer screeninghuman papillomavirusSatisfactionSelf-collected HPV DNA testing

Identifiers

PMID41945938
PMCPMC13609151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.